Advertisement

SKIP ADVERTISEMENT
You have a preview view of this article while we are checking your access. When we have confirmed access, the full article content will load.

Christopher Reeve, 52, Symbol of Courage, Dies

Correction Appended

Christopher Reeve, the cinematic Superman who became a real-life inspiration through his painstaking efforts to overcome total paralysis, while speaking out for stem-cell research and other potential treatments, died on Sunday at Northern Westchester Hospital in Mount Kisco, N.Y. He was 52 and lived in Pound Ridge, N.Y.

Mr. Reeve was being treated for a pressure wound, a common complication for people in wheelchairs, said his publicity agent, Wesley Combs. These wounds result from constant pressure in one spot, reducing the blood to that area and finally killing the affected tissue.

Mr. Combs said that Mr. Reeve fell into a coma on Saturday. The wound had become severely infected, and the infection spread through his body.

A riding accident in 1995 left the actor paralyzed from the neck down. After briefly pondering suicide, Mr. Reeve had become a powerful proponent of causes ranging from insurance reform for catastrophic injuries to unleashing the possibilities some scientists believe lie in using embryonic stem cells for research.

As recently as Friday, Mr. Reeve's name emerged, as it often has, in the national debate over stem cell use. In the presidential debate in St. Louis between President Bush and Senator John F. Kerry, the Democratic challenger, Mr. Kerry mentioned Mr. Reeve by name in arguing against the president's position that stem-cell research must be restricted to protect the lives of human embryos.

Yesterday, the White House issued a statement on behalf of the president and Mrs. Bush, citing Mr. Reeve as "an example of personal courage, optimism and self-determination."


Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.


Thank you for your patience while we verify access.

Already a subscriber? Log in.

Want all of The Times? Subscribe.

Advertisement

SKIP ADVERTISEMENT